Takeda Pharmaceutical Company Limited
TAK
$13.88
$0.010.07%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.37B | 1.93B | 974.51M | 1.01B | 1.27B |
| Total Depreciation and Amortization | 4.79B | 4.83B | 4.80B | 4.82B | 4.81B |
| Total Amortization of Deferred Charges | 219.53M | 219.53M | 219.53M | 219.53M | 193.22M |
| Total Other Non-Cash Items | 972.67M | 553.62M | 805.07M | 702.89M | 144.51M |
| Change in Net Operating Assets | 25.39M | -1.68B | -1.46B | -1.84B | -1.15B |
| Cash from Operations | 7.38B | 5.85B | 5.34B | 4.92B | 5.26B |
| Capital Expenditure | -1.30B | -1.32B | -1.25B | -1.22B | -1.19B |
| Sale of Property, Plant, and Equipment | 318.80K | 2.08M | 59.52M | 59.54M | 66.19M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 195.38M | 187.12M | 150.82M | 134.66M | 62.82M |
| Other Investing Activities | -1.58B | -1.30B | -1.31B | -2.26B | -5.13B |
| Cash from Investing | -2.68B | -2.43B | -2.35B | -3.29B | -6.19B |
| Total Debt Issued | 1.02T | 1.15T | 674.64B | 377.00B | 495.00B |
| Total Debt Repaid | -1.15T | -732.18B | -342.88B | -375.49B | -450.19B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.88B | -1.88B | -1.88B | -2.33B | -2.33B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.96B | -1.95B | -1.95B | -2.01B | -2.03B |
| Other Financing Activities | -79.00B | -72.36B | -15.58B | -66.42B | -56.80B |
| Cash from Financing | -3.40B | 234.87M | 1.59M | -2.45B | -2.11B |
| Foreign Exchange rate Adjustments | 50.52M | -120.61M | 188.20M | 185.26M | 112.52M |
| Miscellaneous Cash Flow Adjustments | -6.70K | -6.70K | 200.00 | -7.10K | -400.00 |
| Net Change in Cash | 1.34B | 3.53B | 3.18B | -630.35M | -2.92B |